Julphar sponsors ICJR Middle East 2016

With its participation in the 5th International Congress for Joint Reconstruction – Middle East (ICJR Middle East) as a Silver sponsor, Julphar is sustaining its presence in orthopaedics big annual events.

 

The three-day orthopaedic Congress, organized by the ICJR Board, was held at the Dubai International Convention & Exhibition Centre from November 3rd to 5th, 2016 and included numerous sessions focusing on the topics of new surgical techniques and advanced tips on shoulder, hip knee, and ankle and sport injuries. Physicians, researchers and students from all around the world took the opportunity to attend an international platform, network with members of the orthopaedic medicine and expand their knowledge of the specialty. During the Congress, leading experts shared updates and news on the latest available orthopaedic-related advanced technology and products.

 

“Our participation in ICJR Middle East 2016 was a good opportunity for Julphar to highlight its continuous efforts to support orthopaedic surgeons,” said Dr Hosam Badr, Marketing Director at Julphar. “The Congress is one of the most important scientific programs for the orthopaedic community and it allowed us to share the benefits of our brands that are relevant to the orthopaedics community: the newly launched product Turox, the fastest once daily Non-Steroidal Anti-inflammatory Drug (NSAD) used for the treatment of painful acute and chronic inflammatory conditions; and the MEBO portfolio, as a complete range for wound and scar management solutions dedicated to post-surgical wounds and chronic wounds with more than 20 years of successful experience in wound healing care.”